Signaling pathways
-
BA3808 BGG463Summary: An inhibitor of type II with oral activity. -
BA3809 ON-013100Summary: ON-013100, an antitumor active molecule.
-
BA3810 CDK8-IN-1Summary: CDK8-IN-1 is a potent and selective inhibitor.
-
BA3811 DalpiciclibSummary: An orally active and highly selective CDK4/6 inhibitor with antitumor activity for breast cancer -
BA3812 IpivivintSummary: Ipivivint is a potent kinase-like inhibitor.
-
BA3813 CK7Summary: CK7 is an inhibitor.
-
BA3814 SRI-29329Summary: SRI-29329 is a specific inhibitor.
-
BA3815 BI-1622Summary: BI-1622 is an orally effective and highly selective inhibitor.
-
BA3816 CDK9-IN-8Summary: CDK9-IN-8 are potent, selective inhibitors.
-
BA3817 GW297361Summary: GW297361 is an oxidized indole inhibitor that elicits a selective response in cells.